New pill aims to speed COVID-19 recovery in early trial

NCT ID NCT07157007

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new drug, ratutrelvir, in adults with mild to moderate COVID-19 who are not in the hospital. About 90 participants will take the drug plus standard care to see if it is safe and helps symptoms go away faster. The goal is to find the right dose for future studies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Chang Gung Memorial Hospital, Linkou Branch

    NOT_YET_RECRUITING

    Taoyuan, Taoyuan, 333, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Chonnam National University Hospital

    NOT_YET_RECRUITING

    Gwangju, Donggu, 61469, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hallym University Sacred Heart Hospital Gangnam

    NOT_YET_RECRUITING

    Seoul, Seoul, 07441, South Korea

    Contact Email: •••••@•••••

  • Inha University Hospital

    NOT_YET_RECRUITING

    Incheon, Jung-gu, 22332, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Kaohsiung Medical University Hospital

    NOT_YET_RECRUITING

    Kaohsiung City, Kaohsiung, 807, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Key Health

    RECRUITING

    Sydney, New South Wales, 2000, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Momentum Clinical Research Taringa

    RECRUITING

    Brisbane, Queensland, 4068, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Novatrial

    RECRUITING

    Charlestown, New South Wales, 2290, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Paratus Clinical(Clinical Trials Institute, Torquay)

    NOT_YET_RECRUITING

    Torquay, Victoria, 3228, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Research Institute of Virology

    RECRUITING

    Tashkent, Tashkent, 100194, Uzbekistan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Taichung Veterans General Hospital

    NOT_YET_RECRUITING

    Taichung, Taichung, 407, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Taipei Medical University Hospital

    NOT_YET_RECRUITING

    Taipei, Taipei, 110, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Taoyuan General Hospital

    NOT_YET_RECRUITING

    Taoyuan, Taoyuan, 33004, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Catholic University of Korea, Eunpyeong St. Mary's Hospital

    NOT_YET_RECRUITING

    Seoul, Eunpyeong-gu, 07441, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Wonju Severance Christian Hospital

    NOT_YET_RECRUITING

    Wŏnju, Gangwon-do, 26426, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••